Burning Rock Biotech (BNR) Non-Current Debt (2019 - 2026)
Burning Rock Biotech (BNR) posted quarterly Non-Current Debt of $246000.0 for Q1 2026, up 2.63% quarter-over-quarter from $239687.4 in Q4 2025.
Burning Rock Biotech (BNR) Non-Current Debt (2019 - 2026) Analysis & Trends
Burning Rock Biotech's Non-Current Debt history runs 4 years deep, the most recent figure standing at $246000.0 for Q1 2026.
- In Q1 2026, Non-Current Debt changed N/A year-over-year to $246000.0; the TTM figure through Mar 2026 stood at $246000.0 (changed N/A YoY), while the FY2025 annual figure was $243000.0, changed N/A from the prior year.
- Non-Current Debt for Q1 2026 stood at $246000.0, up from $239687.4 in the prior quarter.
- The five-year high for Non-Current Debt was $253000.0 in Q3 2025, with the low at $239687.4 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 42.28 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 26.56 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 3.05 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 13.71 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 299.87 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.49 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 2.04 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 5.86 Bn |
| 10 | Burning Rock Biotech | 84.09 Mn | 14.24 Mn | 11.31 Mn | 246,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246,000.00 |
| Dec 31, 2025 | 239,687.42 |
| Sep 30, 2025 | 253,000.00 |
| Jun 30, 2025 | 251,000.00 |
| Jun 30, 2020 | 4.56 Mn |
| Dec 31, 2019 | 2.59 Mn |